The digital rectum exam (DRE) is a test that is used to assess a person’s health, according to a study published on Wednesday.
The study, by the Mayo Clinic, analyzed data from the Mayo Digital Rectal Exam (MDRE) program.
The DRE is a digital exam that can be administered at any doctor’s office and involves a series of tests, including digital rectometry (digital rectum test), physical rectal palpation (PQP), digital rectogram (DPG), digital colonoscopy (DCO), and digital rectoscope (DCL).
The DRE exam is also known as a digital colonoscope, which is a device that is placed over the rectum to examine the colon and determine whether there are any signs of colon cancer.
The Mayo Clinic says the DRE tests can detect cancers that have spread or become resistant to drugs or radiation.
The tests also help doctors better identify and treat cancers.
According to the study, about one in three patients who had an exam from a doctor’s clinic were given the Dre, compared to less than one in five people who received the exam from an office.
However, the Mayo study found that more than half of the people who had the Drem exams at a clinic also had a digital test at the end of the test, which may have been used to diagnose the test.
According the Mayo report, there were also signs of “proximal colon cancer” among the people with a digital examination.
The digital rectums test was used by about 2.3 million people in the U.S. in 2015, according the Mayo data.
The digital exam is now used in more than 120 countries, and is the standard screening tool for colon cancer, according.
The test is also commonly used by doctors to evaluate patients for other conditions, such as diabetes.
The Drem exam was approved by the Food and Drug Administration (FDA) in 2014, and was originally developed by Johns Hopkins University and is approved by about 80 percent of U.K. doctors.
According to the Mayo paper, the test is recommended for people between the ages of 15 and 70.